MICCAI'07 Proceedings of the 10th international conference on Medical image computing and computer-assisted intervention
High throughput analysis of breast cancer specimens on the grid
MICCAI'07 Proceedings of the 10th international conference on Medical image computing and computer-assisted intervention - Volume Part I
Unsupervised segmentation based on robust estimation and color active contour models
IEEE Transactions on Information Technology in Biomedicine
MICCAI '09 Proceedings of the 12th International Conference on Medical Image Computing and Computer-Assisted Intervention: Part II
Computational TMA analysis and cell nucleus classification of renal cell carcinoma
Proceedings of the 32nd DAGM conference on Pattern recognition
A multiple Kernel learning algorithm for cell nucleus classification of renal cell carcinoma
ICIAP'11 Proceedings of the 16th international conference on Image analysis and processing: Part I
Hybrid generative-discriminative nucleus classification of renal cell carcinoma
SIMBAD'11 Proceedings of the First international conference on Similarity-based pattern recognition
Combining data sources nonlinearly for cell nucleus classification of renal cell carcinoma
SIMBAD'11 Proceedings of the First international conference on Similarity-based pattern recognition
Renal cancer cell classification using generative embeddings and information theoretic kernels
PRIB'11 Proceedings of the 6th IAPR international conference on Pattern recognition in bioinformatics
Hi-index | 0.00 |
Renal cell carcinoma (RCC) can be diagnosed by histological tissue analysis where exact counts of cancerous cell nuclei are required. We propose a completely automated image analysis pipeline to predict the survival of RCC patients based on the analysis of immunohistochemical staining of MIB-1 on tissue microarrays. A random forest classifier detects cell nuclei of cancerous cells and predicts their staining. The classifier training is achieved by expert annotations of 2300 nuclei gathered from tissues of 9 different RCC patients. The application to a test set of 133 patients clearly demonstrates that our computational pathology analysis matches the prognostic performance of expert pathologists.